EUVIMEDEUVIMED entdecken
Crossref

QSAR, molecular dynamics, and biological evaluation of novel myeloperoxidase inhibitors via ligand-based pharmacophore modeling as potential anticancer agents

Maysoon Raed Alnajdawi iD, Habibah A Wahab iD, Belal O Al-Najjar iD, Ibrahim D Aldeeb iD, Mansour Al-Sayed Ahmad iD, Ali Attiq iD, Waqas Ahmad iD

Journal of Computer-Aided Molecular Design · 2026

DOI: 10.1007/s10822-026-00895-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Computer-Aided Molecular Design, 2026. Verfasst von Maysoon Raed Alnajdawi und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800, Penang, Malaysia. Hauptthemen laut MEDLINE: Peroxidase, Antineoplastic Agents, Enzyme Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 58 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myeloperoxidase (MPO) has shown promise as a therapeutic target due to its critical role in inflammatory mechanisms and cancer progression. Despite extensive research on MPO inhibitors, the lack of integrated computational-experimental workflows constrains the efficient identification and validation of biologically relevant candidates. Hence, in this study, a ligand-based pharmacophore model of MPO inhibitors was developed to identify crucial molecular features required for inhibition. A quantitative structure-activity relationship (QSAR) model was built using the Genetic Function Approximation (GFA) algorithm, and the model statistics were found to be statistically significant (R2 = 0.765, R2_adj = 0.733, R2_Pred = 0.672, LOF = 1.2). The generated and validated pharmacophore model was used virtually to screen 53,352 compounds, yielding five structurally distinct hits. These hits were subjected to in vitro cytotoxicity analysis using two cancer cell lines. Among all the tested compounds, BTB11556 showed the strongest cytotoxic activity, with an IC50 of 12.5 μM against the Kasumi-1 leukemia cell line, and was therefore considered the lead compound. A one-way ANOVA of the IC50 values for the active compounds in Kasumi-1 cells showed a statistically significant difference in cytotoxic potency (p < 0.001). This integrated computational and experimental approach highlights the importance of pharmacophore-guided virtual screening, combined with QSAR modeling, in the development of MPO inhibitors. The findings from molecular docking, 500-ns molecular dynamics simulations, MM-GBSA calculations, and alanine scanning analyses collectively corroborate a stable binding mode of BTB11556 within the MPO active site. These results support further investigation of BTB11556 as a candidate compound associated with MPO-targeted therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PeroxidaseAntineoplastic AgentsEnzyme InhibitorsQuantitative Structure-Activity RelationshipHumansPharmacophoreMolecular Dynamics SimulationLigandsCell Line, TumorMolecular Docking SimulationDrug Design

Stichwörter der Autor:innen

CancerMolecular dynamicsMyeloperoxidasePharmacophoreQSARVirtual screening

Substanzen

PeroxidaseAntineoplastic AgentsLigandsEnzyme InhibitorsMPO protein, human

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800, Penang, Malaysia.
  • School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800, Penang, Malaysia. habibahw@usm.my.
  • Department of Pharmaceutical Sciences, Faculty of Pharmacy, Al-Ahliyya Amman University, Amman, 19328, Jordan.
  • Diagnostic Research Centre, Al-Ahliyya Amman University, Amman, 19328, Jordan.
  • Department of Pharmacy, Faculty of Health Sciences, American University of Madaba, Madaba, Jordan.
  • School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800, Penang, Malaysia. waqas@usm.my.

ORCID-Profile: Maysoon Raed Alnajdawi, Habibah A Wahab, Belal O Al-Najjar, Ibrahim D Aldeeb, Mansour Al-Sayed Ahmad, Ali Attiq, Waqas Ahmad

Zitieren

APA

Alnajdawi, M. R., Wahab, H. A., Al-Najjar, B. O., Aldeeb, I. D., Ahmad, M. A., Attiq, A., & Ahmad, W. (2026). QSAR, molecular dynamics, and biological evaluation of novel myeloperoxidase inhibitors via ligand-based pharmacophore modeling as potential anticancer agents. Journal of Computer-Aided Molecular Design. https://doi.org/10.1007/s10822-026-00895-2

Vancouver

Alnajdawi MR, Wahab HA, Al-Najjar BO, Aldeeb ID, Ahmad MA, Attiq A, et al. QSAR, molecular dynamics, and biological evaluation of novel myeloperoxidase inhibitors via ligand-based pharmacophore modeling as potential anticancer agents. Journal of Computer-Aided Molecular Design. 2026. doi:10.1007/s10822-026-00895-2

BibTeX
@article{Alnajdawi2026,
  author = {Alnajdawi, Maysoon Raed and Wahab, Habibah A and Al-Najjar, Belal O and Aldeeb, Ibrahim D and Ahmad, Mansour Al-Sayed and Attiq, Ali and Ahmad, Waqas},
  title = {QSAR, molecular dynamics, and biological evaluation of novel myeloperoxidase inhibitors via ligand-based pharmacophore modeling as potential anticancer agents},
  journal = {Journal of Computer-Aided Molecular Design},
  year = {2026},
  doi = {10.1007/s10822-026-00895-2}
}
Kostenlos starten →